THE SCIENCE OF CHARIOT

The world of Multiple Sclerosis has seen dramatic changes over the past decade. From the insights into the critical role of B cells into the precise nature of inflammation.

Over 16 drugs are now licenced to modiify the course of the disease and and mitigate relapses.

 

MS is no longer seen as three seperate diseases but one.

The inflammation behind disability is establised long before the first signs of the disease and is known to be still active to the very last day.

However, not everyone with MS has seen changes to their treatment.

This trial is about those people. 

bcellls1master.jpg
Prof Klaus Schmierer
Prof David Baker
 

A DEEPER DIVE INTO MS